289 related articles for article (PubMed ID: 22907036)
41. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
[TBL] [Abstract][Full Text] [Related]
42. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of new 4-thiazolidinone derivatives.
Güzel O; Salman A
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1015-23. PubMed ID: 19624255
[TBL] [Abstract][Full Text] [Related]
45. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
[TBL] [Abstract][Full Text] [Related]
46. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
Makam P; Kankanala R; Prakash A; Kannan T
Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
[TBL] [Abstract][Full Text] [Related]
47. Antimycobacterial activity: synthesis of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Pandian S; Hassan Ansari MZ
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):598-602. PubMed ID: 21714764
[TBL] [Abstract][Full Text] [Related]
48. New antimycobacterial S-alkylisothiosemicarbazones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
[TBL] [Abstract][Full Text] [Related]
49. Novel phthalazinyl derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme.
Sriram D; Yogeeswari P; Senthilkumar P; Dewakar S; Rohit N; Debjani B; Bhat P; Veugopal B; Pavan VV; Thimmappa HM
Med Chem; 2009 Sep; 5(5):422-33. PubMed ID: 19534678
[TBL] [Abstract][Full Text] [Related]
50. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
51. Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues.
Monga V; Nayyar A; Vaitilingam B; Palde PB; Jhamb SS; Kaur S; Singh PP; Jain R
Bioorg Med Chem; 2004 Dec; 12(24):6465-72. PubMed ID: 15556764
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
Cavicchioli M; Leite CQ; Sato DN; Massabni AC
Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
[TBL] [Abstract][Full Text] [Related]
54. Assessment of antimycobacterial activity of a series of mainly marine derived natural products.
König GM; Wright AD; Franzblau SG
Planta Med; 2000 May; 66(4):337-42. PubMed ID: 10865450
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives.
Güzel O; Salman A
Bioorg Med Chem; 2006 Dec; 14(23):7804-15. PubMed ID: 16931027
[TBL] [Abstract][Full Text] [Related]
56. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
57. Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity.
Novotná E; Waisser K; Kuneš J; Palát K; Skálová L; Szotáková B; Buchta V; Stolaříková J; Ulmann V; Pávová M; Weber J; Komrsková J; Hašková P; Vokřál I; Wsól V
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28635184
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides.
Gonec T; Zadrazilova I; Nevin E; Kauerova T; Pesko M; Kos J; Oravec M; Kollar P; Coffey A; O'Mahony J; Cizek A; Kralova K; Jampilek J
Molecules; 2015 May; 20(6):9767-87. PubMed ID: 26023938
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480.
Sbardella G; Mai A; Artico M; Loddo R; Setzu MG; La Colla P
Bioorg Med Chem Lett; 2004 Mar; 14(6):1537-41. PubMed ID: 15006398
[TBL] [Abstract][Full Text] [Related]
60. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
